Agents for protection from neointimal formation in grafts comprising an nfkb dekoy
CA 2500367 A1 · Owner: Anges Mg, Inc. · Inventors: Sawa, Yoshiki; Shintani, Takuji; Matsuda, Hikaru
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide a method of inhibiting neointimal thickening in a graft by using a decoy against NF.kappa.B and thus regulating (inhibiting) the transcription activated by NF.kappa.B. Also an agent containing a decoy of , NF.kappa.B which protects a vascular graft against intimal thickening.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 27, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.